RxDoctor Payments Data
★ My doctorsLook up a doctor →

Amulya Gottiparthy

Athens, GANPI 1972000842

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations.

$2,663in general payments, 2019–2025

Across 129 payments — averaging $20.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$419
  • AbbVie$370
  • Genentech USA, Inc.$307
  • UCB, Inc.$303
  • CSL Behring$210
  • Takeda Pharmaceuticals U.S.A., Inc.$161
  • plus $893 from 11 others

What the payments were for

  • Food & beverage$2,663100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)21$419
AbbVie20$370
Genentech USA, Inc.17$307
UCB, Inc.11$303
CSL Behring9$210
Takeda Pharmaceuticals U.S.A., Inc.6$161
Argenx US, Inc.6$152
Biogen8$129
EMD Serono, Inc.6$107
Novartis5$101
Acadia Pharmaceuticals Inc4$91
Sanofi4$83
Johnson & Johnson3$65
Pfizer4$62
Otsuka America Pharmaceutical, Inc.2$51
Biohaven Pharmaceutical Holding Company Ltd.2$39
Grifols USA, LLC1$13

Where these figures come from

Is this you, or does something look wrong? →